News

Online Consultation on Global Plan to End TB 2023-2030


5 Apr 2022
by Working Group

On April 01, 2022, the Stop TB Partnership launched the second online consultation for the new Global Plan to End TB 2023-2030. Over the years, the Global Plans have been important tools for advocacy and resource mobilization, and served as a reference document for donors and stakeholders. In May 2021, the Stop TB Partnership held its first online consultation to gather ideas from diverse stakeholders that would guide the direction of the Global Plan 2023 to 2030. Government officials, civil society, technical experts, people affected by the disease, the private sector, among several others, have contributed to this stage of the Global Plan’s development.

In the current phase, the Stop TB Partnership welcomes feedback on an advanced draft of the Global Plan on the following areas:

  • Is the text contained in each draft chapter of the Global Plan factual?
  • Is any part of the draft Global Plan text not relevant to the section, chapter, or the bigger objective of ending TB?
  • Is there critical information missing within the draft Global Plan chapters? (Note: the text is intended to be forward-looking and concise)
  • Is the text easy to understand?

This is an opportunity for you to contribute to the Global Plan to End TB 2023-2030. WGND Members and community are recommended to at least contribute to Chapter 8: R&D for New Tools in TB

The consultation will run from 01 April to 15 April 2022.

Click here to access the online consultation

 

Please note that personal identifiers such as your name, country, or affiliation, as indicated in the survey, will not be displayed publicly. Commentary and input provided through the public consultation will be reviewed and considered to finalize the Global Plan 2023-2030.

More News
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...